|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
US5569467A
(en)
*
|
1993-05-15 |
1996-10-29 |
Societe De Conseils De Recherches Et D'applications (S.C.R.A.S.) |
Process for the preparation of microballs and microballs thus obtained
|
|
GB9310030D0
(en)
*
|
1993-05-15 |
1993-06-30 |
Scras |
Dry processed particles and process for the preparation of the same
|
|
DE69529054T2
(de)
*
|
1994-02-28 |
2003-08-21 |
Nanopharm Ag |
System zur gezielten wirkstoffzufuhr, verfahren zu seiner herstellung und verwendung
|
|
US5980945A
(en)
*
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
|
DE19604744A1
(de)
|
1996-02-09 |
1997-08-14 |
Henkel Kgaa |
Technische Di-/Triglyceridgemische
|
|
DE19617137C1
(de)
*
|
1996-04-29 |
1997-02-27 |
Henkel Kgaa |
Verwendung von Copolymerestern für die Herstellung von Mikrosphären
|
|
AU4571097A
(en)
*
|
1996-10-09 |
1998-05-05 |
Takeda Chemical Industries Ltd. |
A method for producing a microparticle
|
|
TW577759B
(en)
*
|
1997-04-18 |
2004-03-01 |
Ipsen Pharma Biotech |
Sustained release compositions in the form of microcapsules or implants and the process for their preparation
|
|
EP1079967A4
(en)
|
1998-04-13 |
2003-07-23 |
Luminex Corp |
LIQUID MARKING USING FLUORESCENT MICROPARTICLES
|
|
MEP19408A
(en)
*
|
1998-12-16 |
2010-06-10 |
Aventis Pharma Inc |
Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same
|
|
AU5644400A
(en)
*
|
1999-09-24 |
2001-03-29 |
Rohm And Haas Company |
Pellet compositions
|
|
US6458387B1
(en)
*
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
|
US7374782B2
(en)
|
2000-10-27 |
2008-05-20 |
Baxter International Inc. |
Production of microspheres
|
|
US20050233945A1
(en)
*
|
2003-07-18 |
2005-10-20 |
Larry Brown |
Methods for fabrication, uses and compositions of small spherical particles of insulin prepared by controlled phase separation
|
|
DE60226613D1
(de)
*
|
2001-08-16 |
2008-06-26 |
Baxter Int |
Darreichungsformen welche mikropartikel und treibgas enthalten
|
|
US20080026068A1
(en)
*
|
2001-08-16 |
2008-01-31 |
Baxter Healthcare S.A. |
Pulmonary delivery of spherical insulin microparticles
|
|
FR2848113B1
(fr)
*
|
2002-12-04 |
2005-02-25 |
Oreal |
Stabilisation de principes actifs aromatiques par des polymeres aromatiques
|
|
US20040166077A1
(en)
*
|
2002-12-04 |
2004-08-26 |
L'oreal |
Process for treating keratin materials with aromatic active principles
|
|
US20050142205A1
(en)
*
|
2003-07-18 |
2005-06-30 |
Julia Rashba-Step |
Methods for encapsulating small spherical particles prepared by controlled phase separation
|
|
US20070092452A1
(en)
*
|
2003-07-18 |
2007-04-26 |
Julia Rashba-Step |
Methods for fabrication, uses, compositions of inhalable spherical particles
|
|
CA2532874A1
(en)
*
|
2003-07-22 |
2005-02-03 |
Baxter International Inc. |
Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
|
|
US20060135277A1
(en)
*
|
2003-09-10 |
2006-06-22 |
Marnocha Bendict F |
Golf club and practice arrangement
|
|
FR2865938B1
(fr)
*
|
2004-02-05 |
2006-06-02 |
Sod Conseils Rech Applic |
Formulation retard solide comprenant de l'acetate de triptoreline
|
|
EP1765294B1
(en)
*
|
2004-05-12 |
2008-09-24 |
Baxter International Inc. |
Nucleic acid microspheres, production and delivery thereof
|
|
US8728525B2
(en)
*
|
2004-05-12 |
2014-05-20 |
Baxter International Inc. |
Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
|
|
WO2005112893A1
(en)
*
|
2004-05-12 |
2005-12-01 |
Baxter International Inc. |
Microspheres comprising protein and showing injectability at high concentrations of said agent
|
|
WO2005112885A2
(en)
*
|
2004-05-12 |
2005-12-01 |
Baxter International Inc. |
Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
|
|
JP2008506699A
(ja)
*
|
2004-07-13 |
2008-03-06 |
アルテアーナノ,インコーポレーテッド |
薬物転用防止用セラミック構造体
|
|
KR20070042177A
(ko)
*
|
2004-07-13 |
2007-04-20 |
알타이어나노 인코포레이티드 |
약물의 조절 방출을 위한 세라믹 구조체
|
|
JP2008528443A
(ja)
*
|
2004-10-29 |
2008-07-31 |
アドヒーシブズ・リサーチ・インコーポレイテッド |
セキュリティ・アイデンティフィケーションのための微視的なタグ付けシステム
|
|
EP1885335A1
(en)
*
|
2005-04-27 |
2008-02-13 |
BAXTER INTERNATIONAL INC. (a Delaware corporation) |
Surface-modified microparticles and methods of forming and using the same
|
|
AU2006283170A1
(en)
*
|
2005-08-23 |
2007-03-01 |
Altairnano, Inc. |
Highly photocatalytic phosphorus-doped anatase-TiO2 composition and related manufacturing methods
|
|
WO2007103812A1
(en)
*
|
2006-03-02 |
2007-09-13 |
Altairnano, Inc. |
Method for low temperature production of nano-structured iron oxide coatings
|
|
US20080020175A1
(en)
*
|
2006-03-02 |
2008-01-24 |
Fred Ratel |
Nanostructured Indium-Doped Iron Oxide
|
|
WO2007103824A1
(en)
*
|
2006-03-02 |
2007-09-13 |
Altairnano, Inc. |
Nanostructured metal oxides
|
|
US20070281031A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Guohan Yang |
Microparticles and methods for production thereof
|
|
AU2007281737B2
(en)
|
2006-08-04 |
2013-09-19 |
Baxter Healthcare S.A. |
Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
|
|
CA2663589A1
(en)
*
|
2006-10-06 |
2008-05-22 |
Baxter International Inc. |
Microencapsules containing surface-modified microparticles and methods of forming and using the same
|
|
CA2702340C
(en)
|
2006-10-12 |
2014-12-16 |
The University Of Queensland |
Compositions and methods for modulating immune responses
|
|
US20090169628A1
(en)
*
|
2006-10-17 |
2009-07-02 |
Armark Authentication Technologies, Llc |
Article and method for focused delivery of therapeutic and/or diagnostic materials
|
|
US20080254258A1
(en)
*
|
2007-04-12 |
2008-10-16 |
Altairnano, Inc. |
Teflon® replacements and related production methods
|
|
US8808747B2
(en)
*
|
2007-04-17 |
2014-08-19 |
Baxter International Inc. |
Nucleic acid microparticles for pulmonary delivery
|
|
US9782300B2
(en)
|
2008-02-01 |
2017-10-10 |
Kci Licensing, Inc. |
Fiber-microsphere bioresorbable composite scaffold for wound healing
|
|
ES2686708T3
(es)
|
2008-04-18 |
2018-10-19 |
Baxter International Inc. |
Composición basada en microesferas para prevenir y/o revertir la diabetes autoinmune de nueva aparición
|
|
US8367427B2
(en)
*
|
2008-08-20 |
2013-02-05 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
|
US8323615B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing multi-phasic dispersions
|
|
US8323685B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
|
US20100047292A1
(en)
*
|
2008-08-20 |
2010-02-25 |
Baxter International Inc. |
Methods of processing microparticles and compositions produced thereby
|
|
WO2010037021A2
(en)
*
|
2008-09-29 |
2010-04-01 |
Armark Authentication Technologies, Llc |
Spinneret and method of spinning fiber
|
|
US20100291214A1
(en)
*
|
2008-12-23 |
2010-11-18 |
Armark Authentication Technologies, Llc |
Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
|
|
WO2010132763A1
(en)
*
|
2009-05-15 |
2010-11-18 |
Armark Authentication Technologies, Llc |
Fiber having non-uniform composition and method for making same
|
|
MX357630B
(es)
|
2009-05-27 |
2018-07-17 |
Selecta Biosciences Inc |
Nanoportadores sintéticos objetivo con liberación sensible al ph de agentes inmunomoduladores.
|
|
US20110076771A1
(en)
*
|
2009-09-25 |
2011-03-31 |
Armark Authentication Technologies, Llc |
Tissue fiber scaffold and method for making
|
|
EA030813B1
(ru)
|
2010-05-26 |
2018-10-31 |
Селекта Байосайенсиз, Инк |
Способы генерации антительного иммунного ответа и увеличения местной индукции иммунных цитокинов при использовании синтетических наноносителей, соединенных с адъювантами
|
|
EP2399931A1
(fr)
*
|
2010-06-22 |
2011-12-28 |
Ipsen Pharma S.A.S. |
Nouveaux composés octapeptidiques et leur utilisation thérapeutique
|
|
JP2013545453A
(ja)
|
2010-11-01 |
2013-12-26 |
ユニバーシティ・オブ・テクノロジー、シドニー |
免疫変調剤およびそれらの使用
|
|
WO2013019648A1
(en)
|
2011-07-29 |
2013-02-07 |
Selecta Biosciences, Inc. |
Control of antibody responses to synthetic nanocarriers
|
|
US10695406B2
(en)
|
2014-05-27 |
2020-06-30 |
The University Of Queensland |
Modulation of cellular stress using a B-cell oxidative and/or endoplasmic reticulum stress inhibitor and a targeting agent
|
|
FR3067226B1
(fr)
*
|
2017-06-13 |
2021-10-08 |
Rossignol Lange |
Element de chaussure de ski
|